Showing results (551-560 of 638) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2015
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian CancerVianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Circulation|April 9, 2019
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart AssociationSusan C Gilchrist, Ana Barac, Philip A Ades, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
The Journal of Biological Chemistry|September 10, 2010
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisMian M K Shahzad, Jesusa M Arevalo, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector deliveryHaifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Cancer Research|November 3, 2007
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancerCharles N Landen, Yvonne G Lin, Guillermo N Armaiz Pena, et al.
Plos One|May 5, 2012
Differences in iNOS and arginase expression and activity in the macrophages of rats are responsible for the resistance against T. gondii infectionZhi Li, Zhi-Jun Zhao, Xing-Quan Zhu, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Pageof 64